These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17089700)

  • 21. Behavior of nebulizing solutions and suspensions.
    Dahlbäck M
    J Aerosol Med; 1994; 7(Suppl 1):S13-8. PubMed ID: 10147076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydraulic high-pressure nebulization of solutions and dispersions for respiratory drug delivery.
    Moore JM; Pham S; Wiedmann T
    Pharm Dev Technol; 2000; 5(1):105-13. PubMed ID: 10669924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the technical aspects of drug nebulization.
    Le Brun PP; de Boer AH; Heijerman HG; Frijlink HW
    Pharm World Sci; 2000 Jun; 22(3):75-81. PubMed ID: 11028259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution.
    Pham S; Ferguson GT; Kerwin E; Goodin T; Wheeler A; Bauer A
    J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):162-169. PubMed ID: 29125918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical properties of aerosolized immunoglobulin for inhalation therapy.
    Rimensberger PC; Roth C
    J Aerosol Med; 1995; 8(3):255-62. PubMed ID: 10155651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilizing protein formulations during air-jet nebulization.
    Albasarah YY; Somavarapu S; Taylor KM
    Int J Pharm; 2010 Dec; 402(1-2):140-5. PubMed ID: 20933073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perfluorocarbon species and nebulizer type influence aerosolization rate and particle size of perfluorocarbon aerosol.
    Rüdiger M; Gregor T; Burkhardt W; Proquitté H; Wauer RR; Schmalisch G
    J Crit Care; 2004 Mar; 19(1):42-7. PubMed ID: 15101005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerosol Production by Vibrating Membrane Technology: Analysis of the Electrolyte Effect on Generated Droplet Size and Nebulizer Output Rate.
    Beck-Broichsitter M
    J Pharm Sci; 2017 Aug; 106(8):2168-2172. PubMed ID: 28479359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonic and jet aerosolization of phospholipids and the effects on surface activity.
    Marks LB; Notter RH; Oberdorster G; McBride JT
    Pediatr Res; 1983 Sep; 17(9):742-7. PubMed ID: 6622110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers.
    Harris JC; Collins MS; Huang PH; Schramm CM; Nero T; Yan J; Murray TS
    Microbiol Spectr; 2022 Feb; 10(1):e0253521. PubMed ID: 35107362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics.
    Lehofer B; Bloder F; Jain PP; Marsh LM; Leitinger G; Olschewski H; Leber R; Olschewski A; Prassl R
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1076-85. PubMed ID: 25460154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of the technological parameters of ultrasonic nebulization.
    Flament MP; Leterme P; Gayot A
    Drug Dev Ind Pharm; 2001 Aug; 27(7):643-9. PubMed ID: 11694011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology.
    Elhissi A; Gill H; Ahmed W; Taylor K
    J Liposome Res; 2011 Jun; 21(2):173-80. PubMed ID: 20684671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size.
    Sood BG; Peterson J; Malian M; Galli R; Geisor-Walter M; McKinnon J; Sharp J; Maddipati KR
    Pharmacol Res; 2007 Dec; 56(6):531-41. PubMed ID: 17997106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of magnetizable aerosols.
    Baumann R; Glöckl G; Nagel S; Weitschies W
    Eur J Pharm Sci; 2012 Apr; 45(5):693-7. PubMed ID: 22306649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous nebulization therapy for asthma with aerosols of beta2 agonists.
    Raabe OG; Wong TM; Wong GB; Roxburgh JW; Piper SD; Lee JI
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):499-508. PubMed ID: 9647274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features.
    Dailey LA; Schmehl T; Gessler T; Wittmar M; Grimminger F; Seeger W; Kissel T
    J Control Release; 2003 Jan; 86(1):131-44. PubMed ID: 12490379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.
    Elhissi AM; Giebultowicz J; Stec AA; Wroczynski P; Ahmed W; Alhnan MA; Phoenix D; Taylor KM
    Int J Pharm; 2012 Oct; 436(1-2):519-26. PubMed ID: 22796173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.